Pure Omega 3
- Helps Support Cardiovascular Health*
- Helps Support the Immune System*
- Helps Support Overall Health*
Free Shipping on Orders of $49.95 or More
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Pure Omega 3: Overview
Doctor Emi's Pure Omega 3 features a concentrated, purified source of omega-3 fatty acids from sustainably sourced, cold-water fish. Each softgel is enteric-coated and provides 300 mg EPA and 200 mg DHA.*
- Made in the USA
- Manufactured in a GMP Compliant Facility
Produced in a facility that also processes wheat, gluten, milk, egg, soy,
fish, crustacean shellfish, and tree nuts.
Caution: Consult your healthcare practitioner if pregnant, nursing, or taking other nutritional supplements or medications. Keep out of the reach of children.
Pure Omega 3: Directions
Take two softgels 1-3 times daily with food or as directed by your
Pure Omega 3: Storage
Keep tightly closed in a cool, dry place out of the reach of children.
Pure Omega 3: In-Depth Information
Omega-3s are “good fats” found in every cell in the human
body. They are considered conditionally essential because
they arenʼt produced by the body, so they must be obtained
from foods or supplementation. The most widely researched
omega-3s are eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA). EPA and DHA supplements are
commonly referred to as “fish oils” because coldwater fish such
as mackerel, menhaden, salmon, and tuna are major sources.
Other common sources include calamari, krill, and other
Omega-3s and Cardiovascular Health
A number of studies of endogenous fatty acid profiles suggest
that higher concentrations of omega-3s decrease the risk of a
number of concerns that have been associated with
cardiovascular disease development—including abdominal
obesity, higher liver fat content, and elevated blood lipids. *[1,2,3,4]
Omega-3 fatty acids (including EPA and DHA) have been
examined in previous clinical and epidemiological research that has shown they may: *[4-15]
- Keep cell membranes fluid, flexible, and permeable to function properly
- Reduce certain pro-inflammatory signals and activities (e.g.,oxidative stress)
- Regulate genetic expression in favor of health
- Promote healthy blood flow and decrease the growth rate of atherosclerotic plaque
- Reduce LDL cholesterol levels
- Increase HDL cholesterol levels
- Reduce triglyceride levels
- Lower blood pressure (slightly)
- Decrease the risk of fatal arrhythmias
- Decrease the chance of stroke
Though EPA and DHA have individually shown to beneficially
influence certain functions to a greater extent than the other,
the bulk of research focuses on their combined use to support
overall cardiovascular health. Their complementary effects also suggest their combined use to support cardiovascular health. *
1. Garaulet M, Hernandez-Morante JJ, Tebar FJ, Zamora S. Relation between
degree of obesity and site-specific adipose tissue fatty acid composition in a
Mediterranean population. Nutrition. 2011;27(2):170-176.
2. Kawashima A, Sugawara S, Okita M, et al. Plasma fatty acid composition,
estimated desaturase activities, and intakes of energy and nutrient in
Japanese men with abdominal obesity or metabolic syndrome. J Nutr Sci
Vitaminol (Tokyo). 2009;55(5):400-406.
3. Fabbrini E, Magkos F, Su X, et al. Insulin sensitivity is not associated with
palmitoleate availability in obese humans. J Lipid Res. 2011;52(4): 808-812.
4. Sun Q, Ma J, Campos H, et al. Blood concentrations of individual long-chain
n-3 fatty acids and risk of nonfatal myocardial infarction. Am J Clin Nutr.
5. Mozaffarian D, Wu JH. (n-3) fatty acids and cardiovascular health: are
effects of EPA and DHA shared or complementary? J Nutr.
6. Mozaffarian D, Lemaitre RN, King IB, et al. Circulating long-chain ω-3 fatty
acids and incidence of congestive heart failure in older adults: the
cardiovascular health study: a cohort study. Ann Intern Med. 2011;155:160-
7. Balk E, Chung M, Lichtenstein A, et al. Effects of omega-3 fatty acids on
cardiovascular risk factors and intermediate markers of cardiovascular
disease. Evid Rep Technol Assess. 2004;(93).
8. Pauwels EK, Kostkiewicz M. Fatty acid facts, Part III: cardiovascular
disease, or, a fish diet is not fish. Drug News Perspect. 2008;21(10):552-
9. Harris WS, Park Y, Isley WL. Cardiovascular disease and long-chain omega-
3 fatty acids. Curr Opin Lipidol. 2003;14(1):9-14.
10. Carroll DN, Roth MT. Evidence of the cardioprotective effects of omega-3
fatty acids. Ann Pharmacother. 2002;36(12):1950-1956.
11. Schrepf, R. Clinical prevention of sudden cardiac death by n-3
polyunsaturated fatty acids and mechanism of prevention of arrhythmias by
n-3 fish oils. The Lancet. 2004;363:1441-1442.
12. Biscione F, Totteri A, De Vita A, Lo Bianco F, Altamura G. Effect of omega-3
fatty acids on the prevention of atrial arrhythmias. Ital Heart J Suppl.
13. Leaf A, Kang JX, Xiao YF, Billman GE. Clinical prevention of sudden cardiac
death by n-3 polyunsaturated fatty acids and mechanism of prevention of
arrhythmias by n-3 fish oils. Circulation. 2003;107(21):2646-2652.
14. Mozaffarian D, Psaty BM, Rimm EB, et al. Fish intake and risk of incident
atrial fibrillation. Circulation. 2004;110(4):368-373.
15. He K, Rimm EB, Merchant A, et al. Fish consumption and risk of stroke in
men. JAMA. 2002;288(24):3130-3136.